Skip to content
Screener

Xencor XNCR Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Amgen logo
AmgenAMGN
$2.45B+4.7%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$2.28B+34.1%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$9.71M+523%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$3.29M—
Sutro Biopharma logo
Sutro BiopharmaSTRO
$1.69M0.0%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$0-100%

Other financials

Income statement

See full
Revenue$51.2M+17.5%
Operating income-$37.1M-11.7%
Net income-$21.7M+29.5%
EPS (diluted)-$0.29+29.3%

Balance sheet

See full
Cash & equivalents$44.7M+0.5%
Total debt$170.1M-20.1%
Total equity$503.2M-18.9%
Total assets$725.0M-17.6%

Cash flow

See full
Operating cash flow-$55.7M-53.0%
CapEx$538.0K+40.5%
Free cash flow-$56.2M-52.9%

Valuation

See full
Market cap$1.55B+210%
Enterprise value$1.67B+150%
P/S14.7×+11.3×

Profitability

See full
Operating margin-205.8%-2,501pp
Net margin-155.6%+78.8pp
FCF margin-198.4%-1,485pp

Returns & leverage

See full
Return on equity-29.1%+0.2pp
Debt / equity0.3×0.0×
Current ratio6.4×+1.1×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The source filing: Xencor’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:02 PM EDT
Fiscal quarter
Q4 FY2028
Calendar quarter
Q4 2028
Accession
0001326732-26-000056

FAQ

What is Xencor's other non-current liabilities?
Xencor (XNCR) reported other non-current liabilities of $152K in Q2 2026.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.

Ask your AI about Xencor's other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude